Implication of STARD5 and cholesterol homeostasis disturbance in the endoplasmic reticulum stress-related response induced by pro-apoptotic aminosteroid RM-133.

Abstract:

:The aminosteroid derivative RM-133 is an effective anticancer molecule for which proof of concept has been achieved in several mouse xenograph models (HL-60, MCF-7, PANC-1 and OVCAR-3). To promote this new family of molecules toward a clinical phase 1 trial, the mechanism of action governing the anticancer properties of the representative candidate RM-133 needs to be characterized. In vitro experiments were first used to determine that RM-133 causes apoptosis in cancer cells. Then, using proteomic and transcriptomic experiments, RM-133 cytotoxicity was proven to be achieved via the endoplasmic reticulum (ER)-related apoptosis, which characterizes RM-133 as an endoplasmic reticulum stress aggravator (ERSA) anticancer drug. Furthermore, an shRNA-genome-wide screening has permitted to identify the steroidogenic acute regulator-related lipid transfer protein 5 (STARD5) as a major player in the RM-133 ER-related apoptosis mechanism, which was validated by an in vitro binding experiment. Altogether, the results presented herein suggest that RM-133 provokes a disturbance of cholesterol homeostasis via the implication of STARD5, which delivers an ERSA molecule to the ER. These results will be a springboard for RM-133 in its path toward clinical use.

journal_name

Pharmacol Res

journal_title

Pharmacological research

authors

Perreault M,Maltais R,Kenmogne LC,Létourneau D,LeHoux JG,Gobeil S,Poirier D

doi

10.1016/j.phrs.2017.12.024

subject

Has Abstract

pub_date

2018-02-01 00:00:00

pages

52-60

eissn

1043-6618

issn

1096-1186

pii

S1043-6618(17)30634-5

journal_volume

128

pub_type

杂志文章
  • Cholinesterase inhibitors: new roles and therapeutic alternatives.

    abstract::An important aspect of brain cholinesterase function is related to enzymatic differences. The brain of mammals contains two major forms of cholinesterases: acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). The two forms differ genetically, structurally and for their kinetics. Butyrylcholine is not a physi...

    journal_title:Pharmacological research

    pub_type: 杂志文章,评审

    doi:10.1016/j.phrs.2003.11.017

    authors: Giacobini E

    更新日期:2004-10-01 00:00:00

  • Effects of acetylbergenin against D -galactosamine-induced hepatotoxicity in rats.

    abstract::The hepatoprotective effects of acetylbergenin were examined against D -galactosamine (GalN)-induced liver damage in rats, compared with that of bergenin reported previously. Acetylbergenin was synthesized from acetylation of bergenin, isolated from Mallotus japonicus, to increase lipophilic and physiological activiti...

    journal_title:Pharmacological research

    pub_type: 杂志文章

    doi:10.1006/phrs.2000.0730

    authors: Lim HK,Kim HS,Choi HS,Oh S,Jang CG,Choi J,Kim SH,Chang MJ

    更新日期:2000-11-01 00:00:00

  • Brain microRNAs dysregulation: Implication for missplicing and abnormal post-translational modifications of tau protein in Alzheimer's disease and related tauopathies.

    abstract::MicroRNAs (miRNAs) are small non-coding RNAs that regulate post-transcriptional gene expression by targeting specific mRNAs for degradation or translation repression. Changes in miRNAs expression profiles have been reported in several neurodegenerative disorders such as Alzheimer's disease (AD) and related tauopathies...

    journal_title:Pharmacological research

    pub_type: 杂志文章,评审

    doi:10.1016/j.phrs.2020.104729

    authors: Bazrgar M,Khodabakhsh P,Mohagheghi F,Prudencio M,Ahmadiani A

    更新日期:2020-05-01 00:00:00

  • The development of medicines for children. Part of a series on Pediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni.

    abstract::The lack of availability of appropriate medicines for children is an extensive and well known problem. As a consequence off label or unlicensed administration of medicinal products in every day paediatric practice is frequent. A variety of obstacles hinder the development of paediatric indications for drugs primarily ...

    journal_title:Pharmacological research

    pub_type: 社论,评审

    doi:10.1016/j.phrs.2011.01.016

    authors: Rocchi F,Tomasi P

    更新日期:2011-09-01 00:00:00

  • PIM1 kinase inhibitors induce radiosensitization in non-small cell lung cancer cells.

    abstract::Radiotherapy plays a critical role in the treatment of non-small cell lung cancer (NSCLC). However, radioresistance is a major barrier against increasing the efficiency of radiotherapy for NSCLC. To understand the mechanisms underlying NSCLC radioresistance, we previously focused on the potential involvement of PIM1, ...

    journal_title:Pharmacological research

    pub_type: 杂志文章

    doi:10.1016/j.phrs.2013.01.005

    authors: Kim W,Youn H,Kwon T,Kang J,Kim E,Son B,Yang HJ,Jung Y,Youn B

    更新日期:2013-04-01 00:00:00

  • Anti-hypertensive mechanisms of cyclic depsipeptide inhibitor ligands for Gq/11 class G proteins.

    abstract::Augmented vasoconstriction is a hallmark of hypertension and is mediated partly by hyper-stimulation of G protein couple receptors (GPCRs) and downstream signaling components. Although GPCR blockade is a key component of current anti-hypertensive strategies, whether hypertension is better managed by directly targeting...

    journal_title:Pharmacological research

    pub_type: 杂志文章

    doi:10.1016/j.phrs.2019.01.012

    authors: Meleka MM,Edwards AJ,Xia J,Dahlen SA,Mohanty I,Medcalf M,Aggarwal S,Moeller KD,Mortensen OV,Osei-Owusu P

    更新日期:2019-03-01 00:00:00

  • Effect of conivaptan, a combined vasopressin V(1a) and V(2) receptor antagonist, on vasopressin-induced cardiac and haemodynamic changes in anaesthetised dogs.

    abstract::The neurohormonal factor arginine vasopressin (AVP) produces potent systemic vasoconstriction as well as water retention in the kidneys via the V(1a) and V(2) receptors, respectively. Therefore, AVP may be considered as an aggravating factor of cardiac failure. In the present study, the effects of intravenous (i.v.) i...

    journal_title:Pharmacological research

    pub_type: 杂志文章

    doi:10.1016/s1043661802002062

    authors: Yatsu T,Kusayama T,Tomura Y,Arai Y,Aoki M,Tahara A,Wada K,Tsukada J

    更新日期:2002-11-01 00:00:00

  • Thiamin status in furosemide-treated rats.

    abstract::Rats were treated with furosemide at intraperitoneal doses of 10, 20, and 30 mg kg(-1)day(-1)for 21 days, and some indices of thiamin status (liver, blood and urine thiamin concentrations, erythrocyte transketolase (TK) activity, and thiamin pyrophosphate (TPP) effect, which refers to the increase in TK activity in a ...

    journal_title:Pharmacological research

    pub_type: 杂志文章

    doi:10.1006/phrs.1999.0632

    authors: Ali BH,Al-Qarawi AA

    更新日期:2000-07-01 00:00:00

  • Bmi1 drives the formation and development of intrahepatic cholangiocarcinoma independent of Ink4A/Arf repression.

    abstract::Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) are the most prevalent types of primary liver cancer. Compared with HCC, for which several drugs have been approved, ICC is associated with shorter survival, and no drug has been approved for this type. Previously, we reported that Bmi1 drives HC...

    journal_title:Pharmacological research

    pub_type: 杂志文章

    doi:10.1016/j.phrs.2020.105365

    authors: Guo J,Deng N,Xu Y,Li L,Kuang D,Li M,Li X,Xu Z,Xiang M,Xu C

    更新日期:2020-12-08 00:00:00

  • An in vitro study of inhibitory activity of gossypol, a cottonseed extract, in human carcinoma cell lines.

    abstract::Gossypol, a cottonseed extract, has been shown to have antiproliferative activity in a variety of cancer cell lines. The objective of this study was to determine the inhibitory effects of gossypol on cell proliferation. Five human carcinoma cell lines were evaluated including endometrial (RL95-2), ovarian (SKOV-3), me...

    journal_title:Pharmacological research

    pub_type: 杂志文章

    doi:10.1016/s104366180200230x

    authors: Le Blanc M,Russo J,Kudelka AP,Smith JA

    更新日期:2002-12-01 00:00:00

  • Anti-cancerous efficacy and pharmacokinetics of 6-mercaptopurine loaded chitosan nanoparticles.

    abstract::6-Mercaptopurine is a cytotoxic and immunosuppressant drug. The use of this drug is limited due to its poor bioavailability and short plasma half-life. In order to nullify these drawbacks, 6-mercaptopurine-chitosan nanoparticles (6-MP-CNPs) were prepared and evaluated to study the influence of preparation conditions o...

    journal_title:Pharmacological research

    pub_type: 杂志文章

    doi:10.1016/j.phrs.2015.07.025

    authors: Kumar GP,Sanganal JS,Phani AR,Manohara C,Tripathi SM,Raghavendra HL,Janardhana PB,Amaresha S,Swamy KB,Prasad RG

    更新日期:2015-10-01 00:00:00

  • Diet-induced reduction in serum lipoproteins stimulates cell proliferation in weanling rats.

    abstract::Male weanling Wistar rats were fed a 4% cholestyramine diet and used as a model to demonstrate that a reduction in serum low density lipoproteins stimulates de novo cholesterogenesis leading to DNA synthesis and cell proliferation. Feeding this diet resulted in a decrease in serum very low density lipoproteins and low...

    journal_title:Pharmacological research

    pub_type: 杂志文章

    doi:10.1016/1043-6618(89)90195-3

    authors: Kazanecki ME,Melhem MF,Spichty KJ,Kelly RH,Rao KN

    更新日期:1989-09-01 00:00:00

  • Effects of clonidine on the experimental hypertension by abdominal aortic coarctation in rats.

    abstract::Cardiovascular baroreflex mechanisms and sympathetic tone could be involved in the arterial hypertension by coarctation of abdominal aorta artery (CoA). The present work analyzes the effect on the arterial pressure and heart rate (HR) of the clonidine, an alpha(2)-adrenergic central acting antihypertensive agent, afte...

    journal_title:Pharmacological research

    pub_type: 杂志文章

    doi:

    authors: Gorzalczany SB,Opezzo JA,del Carmen Garcia M,Taira CA

    更新日期:2003-07-01 00:00:00

  • Uncariitannin, a polyphenolic polymer from Uncaria gambier, attenuates Staphylococcus aureus virulence through an MgrA-mediated regulation of α-hemolysin.

    abstract::A global transcriptional regulator, MgrA, was previously identified as a key determinant of virulence in Staphylococcus aureus. An 80% EtOH extract of Uncaria gambier was found to attenuate the virulence of S. aureus via its effects on MgrA. Using bioassay-guided fractionation, a polyphenolic polymer, uncariitannin, w...

    journal_title:Pharmacological research

    pub_type: 杂志文章

    doi:10.1016/j.phrs.2019.104328

    authors: Zhang H,Jiang JM,Han L,Lao YZ,Zheng D,Chen YY,Wan SJ,Zheng CW,Tan HS,Li ZG,Xu HX

    更新日期:2019-09-01 00:00:00

  • Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy.

    abstract::Most solid tumor cells adapt to their heterogeneous microenvironment by depending largely on aerobic glycolysis for energy production, a phenomenon called the Warburg effect, which is a hallmark of cancer. The altered energy metabolism not only provides cancer cell with ATP for cellular energy, but also generate essen...

    journal_title:Pharmacological research

    pub_type: 杂志文章,评审

    doi:10.1016/j.phrs.2019.104511

    authors: Abdel-Wahab AF,Mahmoud W,Al-Harizy RM

    更新日期:2019-12-01 00:00:00

  • Regulation of endothelin-converting enzyme-1 (ECE-1) by the calcimimetic R-568.

    abstract::Although calcimimetics were developed to block parathyroid hormone synthesis, some reports suggest that they may also reduce blood pressure by unknown mechanisms. Calcimimetic-induced changes in the synthesis of endothelial vasoactive factors could be involved. Wistar rats were treated with the calcimimetic R-568, and...

    journal_title:Pharmacological research

    pub_type: 杂志文章

    doi:10.1016/j.phrs.2013.07.006

    authors: Martínez-Miguel P,Medrano-Andrés D,Lopes-Martín V,Arribas-Gómez I,Rodríguez-Puyol M,Rodríguez-Puyol D,López-Ongil S

    更新日期:2013-10-01 00:00:00

  • Tumor deconstruction as a tool for advanced drug screening and repositioning.

    abstract::A major focus of contemporary drug screening strategies is the identification of novel anticancer compounds, which often results in underutilization of resources. Current drug evaluation involves in vivo tumor (xenograft) regression as proof-of-principle for cytotoxicity (POC). However, this end-point lacks any assess...

    journal_title:Pharmacological research

    pub_type: 杂志文章

    doi:10.1016/j.phrs.2016.07.018

    authors: Naik RR,Luo T,Kohandel M,Bapat SA

    更新日期:2016-09-01 00:00:00

  • Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions.

    abstract::Drug-drug interactions (DDI) potentially occurring between medications used in the course of COVID-19 infection and medications prescribed for the management of underlying comorbidities may cause adverse drug reactions (ADRs) contributing to worsening of the clinical outcome in affected patients. First, we conducted a...

    journal_title:Pharmacological research

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.phrs.2020.105250

    authors: Awortwe C,Cascorbi I

    更新日期:2020-11-01 00:00:00

  • Pharmacokinetic and chemoprevention studies on tea in humans.

    abstract::Green tea and its major polyphenols constituents, tea catechins, have been shown to have many health benefits including cancer prevention. Tea catechins and tea catechin metabolites/catabolites are bioavailable in the systemic circulation after oral intake of green tea or green tea catechins. The metabolites/catabolit...

    journal_title:Pharmacological research

    pub_type: 杂志文章,评审

    doi:10.1016/j.phrs.2011.05.007

    authors: Chow HH,Hakim IA

    更新日期:2011-08-01 00:00:00

  • Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system.

    abstract::Coronavirus Disease 2019 (COVID-19) caused by the emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with a crude case fatality rate of about 0.5-10 % depending on locality. A few clinically approved drugs, such as remdesivir, chloroquine, hydroxychloroquine, nafamostat, camostat, and ...

    journal_title:Pharmacological research

    pub_type: 杂志文章

    doi:10.1016/j.phrs.2020.104960

    authors: Yuan S,Chan JFW,Chik KKH,Chan CCY,Tsang JOL,Liang R,Cao J,Tang K,Chen LL,Wen K,Cai JP,Ye ZW,Lu G,Chu H,Jin DY,Yuen KY

    更新日期:2020-09-01 00:00:00

  • Identification of an IKKβ inhibitor for inhibition of inflammation in vivo and in vitro.

    abstract::Targeting on the IKKβ to discover anti-inflammatory drugs has been launched for ten years, due to its predominant role in canonical NF-κB signaling. In the current study, we identified a novel IKKβ inhibitor, ellipticine (ELL), an alkaloid isolated from Ochrosia elliptica and Rauvolfia sandwicensis. We found that ELL ...

    journal_title:Pharmacological research

    pub_type: 杂志文章

    doi:10.1016/j.phrs.2019.104440

    authors: Chen Q,Liu J,Zhuang Y,Bai LP,Yuan Q,Zheng S,Liao K,Khan MA,Wu Q,Luo C,Liu L,Wang H,Li T

    更新日期:2019-11-01 00:00:00

  • Mitochondrial quality orchestrates muscle-adipose dialog to alleviate dietary obesity.

    abstract::Skeletal muscle fitness is vital for human health and disease and is determined by the capacity for burning fuel, mitochondrial ATP production, and contraction. High quality mitochondria in skeletal muscle are essential for maintaining energy homeostasis in response to a myriad of physiologic or pathophysiological str...

    journal_title:Pharmacological research

    pub_type: 杂志文章,评审

    doi:10.1016/j.phrs.2018.12.020

    authors: Xu Z,Fu T,Guo Q,Sun W,Gan Z

    更新日期:2019-03-01 00:00:00

  • Modulation of inflammatory paw oedema by cysteamine in the rat.

    abstract::Cysteamine, a potent somatostatin depletor, was used in the present study to investigate the role of endogenous somatostatin in acute peripheral inflammation. The acute inflammation was induced by intraplantar injection of carrageenan (1%), histamine (5 micromol), or formalin (2.5%) in the rat hind paw. The induced in...

    journal_title:Pharmacological research

    pub_type: 杂志文章

    doi:10.1006/phrs.2002.0955

    authors: Salam OM

    更新日期:2002-04-01 00:00:00

  • Direct inotropic effects of propofol and adenosine on rat atrial muscle: possible mechanisms.

    abstract::Experiments were designed to evaluate the mechanisms of propofol and adenosine in rat atrial muscle. Atria were suspended in the isolated organ bath system for isometric tension recording and response to propofol and adenosine were tested in the absence and presence of glibenclamide, N(G)-nitro-arginine-methyl-ester (...

    journal_title:Pharmacological research

    pub_type: 杂志文章

    doi:10.1006/phrs.2000.0666

    authors: Cinel I,Gür S

    更新日期:2000-08-01 00:00:00

  • Altered expression of connexin 43 and related molecular partners in a pig model of left ventricular dysfunction with and without dipyrydamole therapy.

    abstract::Gap junctions (GJ) mediate electrical coupling between cardiac myocytes, allowing the spreading of the electrical wave responsible for synchronized contraction. GJ function can be regulated by modulation of connexon densities on membranes, connexin (Cx) phosphorylation, trafficking and degradation. Recent studies have...

    journal_title:Pharmacological research

    pub_type: 杂志文章

    doi:10.1016/j.phrs.2015.03.015

    authors: Del Ry S,Moscato S,Bianchi F,Morales MA,Dolfi A,Burchielli S,Cabiati M,Mattii L

    更新日期:2015-05-01 00:00:00

  • Effect of vitamins C and E on cognitive function in mouse.

    abstract::The aim of this study was to verify the role of Vitamins C and E on the cognitive function of young and aged mice. First and second groups of young animals (aged 3 months) received either Vitamin E (250mg/kg per day) or Vitamin C (300mg/kg per day) for 60 days. Third group was treated with the combination of Vitamin E...

    journal_title:Pharmacological research

    pub_type: 杂志文章

    doi:10.1016/j.phrs.2003.10.004

    authors: Arzi A,Hemmati AA,Razian A

    更新日期:2004-03-01 00:00:00

  • Mechanisms involved in the relaxant action of testosterone in the renal artery from male normoglycemic and diabetic rabbits.

    abstract::Kidney disease is a frequent complication in diabetes, and significant differences have been reported between male and female patients. Our working hypothesis was that diabetes might modify the vascular actions of testosterone in isolated rabbit renal arteries and the mechanisms involved in these actions. Testosterone...

    journal_title:Pharmacological research

    pub_type: 杂志文章

    doi:10.1016/j.phrs.2009.09.002

    authors: Marrachelli VG,Miranda FJ,Centeno JM,Burguete MC,Castelló-Ruiz M,Jover-Mengual T,Pérez AM,Salom JB,Torregrosa G,Alborch E

    更新日期:2010-02-01 00:00:00

  • Endothelin-1 (ET-1) and vein graft failure and the therapeutic potential of ET-1 receptor antagonists.

    abstract::Despite the exploration of a large number of disparate drugs in animal models and clinical trials, no pharmacological intervention, with the exception of aggressive lipid lowering therapy has reduced late vein graft failure in man. The importance of devising more effective strategies is exemplified by the enormous eco...

    journal_title:Pharmacological research

    pub_type: 杂志文章,评审

    doi:10.1016/j.phrs.2010.10.018

    authors: Jeremy JY,Shukla N,Angelini GD,Wan S

    更新日期:2011-06-01 00:00:00

  • Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug.

    abstract::We report a first-in-patient study of vamorolone, a first-in-class dissociative steroidal anti-inflammatory drug, in Duchenne muscular dystrophy. This 2-week, open-label Phase IIa multiple ascending dose study (0.25, 0.75, 2.0, and 6.0 mg/kg/day) enrolled 48 boys with Duchenne muscular dystrophy (4 to <7 years), with ...

    journal_title:Pharmacological research

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.phrs.2018.09.007

    authors: Conklin LS,Damsker JM,Hoffman EP,Jusko WJ,Mavroudis PD,Schwartz BD,Mengle-Gaw LJ,Smith EC,Mah JK,Guglieri M,Nevo Y,Kuntz N,McDonald CM,Tulinius M,Ryan MM,Webster R,Castro D,Finkel RS,Smith AL,Morgenroth LP,Arrieta

    更新日期:2018-10-01 00:00:00

  • Etrolizumab versus infliximab in the treatment of induction phase of ulcerative colitis: A systematic review and indirect comparison.

    abstract:OBJECTIVES:There is still a need to develop new effective medications for the treatment of ulcerative colitis, particularly for patients who are intolerant or resistant to first line therapies. This article compared the efficacy and safety of etrolizumab and infliximab in moderate to severe ulcerative colitis. METHODS...

    journal_title:Pharmacological research

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.phrs.2018.11.003

    authors: Motaghi E,Ghasemi-Pirbaluti M,Zabihi M

    更新日期:2019-01-01 00:00:00